Kohlberg Kravis Roberts & Co »

Bridgebio Pharma shares owned by Kohlberg Kravis Roberts & Co

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Kohlberg Kravis Roberts & Co from 13F filings

Historical chart of Kohlberg Kravis Roberts & Co investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Kohlberg Kravis Roberts & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Kohlberg Kravis Roberts & Co

Quarter filed Position value Share count Share price at filing
2026-06-30 $649k 385k 1.68

More positions owned by Kohlberg Kravis Roberts & Co

Brightspring Health Svcs (BTSG)
Henry Schein (HSIC)
Bridgebio Pharma (BBIO)
Brightview Holdings (BV)
Crescent Energy Company Cl A Com (CRGY)
Niq Global Intelligence Ordinary Shares (NIQ)
Gmr Solutions Com Cl A
Kkr Real Estate Finance Trust (KREF)
Paramount Skydance Corp Com Cl B (PSKY)
Ncl Corp Note 0.875% 4/1 (Principal)
Bausch Health Companies (BHC)
Lci Inds Note 3.000% 3/0 (Principal)
Firstenergy Corp Note 3.625% 1/1 (Principal)
Akamai Technologies Note 0.250% 5/1 (Principal)
Oxford Lane Cap Corp (OXLC)

View all positions for Kohlberg Kravis Roberts & Co

Top funds holding Bridgebio Pharma

OZ Management
Camden Asset Management
Franklin Resources
Wolverine Asset Management
Ubs Global Asset Management Americas
Sunrise Partners Limited Partnership
Invesco
Citadel Advisors
Susquehanna Advisors Group
Alberta Investment Management Corporation
Aristeia Capital
BlackRock
Jpmorgan Chase & Co
Ameriprise Financial
Bank of America Corporation

View all funds holding Bridgebio Pharma